Dose-Dependent Effects of FKRP Gene-Replacement Therapy on Functional Rescue and Longevity in Dystrophic Mice

Kanagawa, 2016, Identification of a post-translational modification with ribitol-phosphate and its defect in muscular dystrophy, Cell Rep., 14, 2209, 10.1016/j.celrep.2016.02.017

Brockington, 2001, Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C, Hum. Mol. Genet., 10, 2851, 10.1093/hmg/10.25.2851

Inamori, 2012, Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE, Science, 335, 93, 10.1126/science.1214115

Briggs, 2016, Structural basis of laminin binding to the LARGE glycans on dystroglycan, Nat. Chem. Biol., 12, 810, 10.1038/nchembio.2146

Rader, 2016, Role of dystroglycan in limiting contraction-induced injury to the sarcomeric cytoskeleton of mature skeletal muscle, Proc. Natl. Acad. Sci. USA, 113, 10992, 10.1073/pnas.1605265113

Amberger, 2011, A new face and new challenges for Online Mendelian Inheritance in Man (OMIM®), Hum. Mutat., 32, 564, 10.1002/humu.21466

Cormand, 2001, Clinical and genetic distinction between Walker-Warburg syndrome and muscle-eye-brain disease, Neurology, 56, 1059, 10.1212/WNL.56.8.1059

Beltran-Valero de Bernabé, 2004, Mutations in the FKRP gene can cause muscle-eye-brain disease and Walker-Warburg syndrome, J. Med. Genet., 41, e61, 10.1136/jmg.2003.013870

Van Reeuwijk, 2010, A homozygous FKRP start codon mutation is associated with Walker-Warburg syndrome, the severe end of the clinical spectrum, Clin. Genet., 78, 275, 10.1111/j.1399-0004.2010.01384.x

Brockington, 2001, Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan, Am. J. Hum. Genet., 69, 1198, 10.1086/324412

Mercuri, 2003, Phenotypic spectrum associated with mutations in the fukutin-related protein gene, Ann. Neurol., 53, 537, 10.1002/ana.10559

Mercuri, 2006, Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations, Arch. Neurol., 63, 251, 10.1001/archneur.63.2.251

Esapa, 2002, Functional requirements for fukutin-related protein in the Golgi apparatus, Hum. Mol. Genet., 11, 3319, 10.1093/hmg/11.26.3319

Chan, 2010, Fukutin-related protein is essential for mouse muscle, brain and eye development and mutation recapitulates the wide clinical spectrums of dystroglycanopathies, Hum. Mol. Genet., 19, 3995, 10.1093/hmg/ddq314

Kawahara, 2010, Zebrafish models for human FKRP muscular dystrophies, Hum. Mol. Genet., 19, 623, 10.1093/hmg/ddp528

Blaeser, 2013, Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes, Hum. Genet., 132, 923, 10.1007/s00439-013-1302-7

Whitmore, 2014, The transgenic expression of LARGE exacerbates the muscle phenotype of dystroglycanopathy mice, Hum. Mol. Genet., 23, 1842, 10.1093/hmg/ddt577

Gicquel, 2017, AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression, Hum. Mol. Genet., 26, 1952, 10.1093/hmg/ddx066

Xu, 2013, Adeno-associated virus 9 mediated FKRP gene therapy restores functional glycosylation of α-dystroglycan and improves muscle functions, Mol. Ther., 21, 1832, 10.1038/mt.2013.156

Vannoy, 2014, Adeno-associated virus-mediated overexpression of LARGE rescues α-dystroglycan function in dystrophic mice with mutations in the fukutin-related protein, Hum. Gene Ther. Methods, 25, 187, 10.1089/hgtb.2013.151

Fisher, 1997, Recombinant adeno-associated virus for muscle directed gene therapy, Nat. Med., 3, 306, 10.1038/nm0397-306

Daya, 2008, Gene therapy using adeno-associated virus vectors, Clin. Microbiol. Rev., 21, 583, 10.1128/CMR.00008-08

Samulski, 2014, AAV-mediated gene therapy for research and therapeutic purposes, Annu. Rev. Virol., 1, 427, 10.1146/annurev-virology-031413-085355

Blaeser, 2016, Progressive dystrophic pathology in diaphragm and impairment of cardiac function in FKRP P448L mutant mice, PLoS ONE, 11, e0164187, 10.1371/journal.pone.0164187

Hinderer, 2018, Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN, Hum. Gene Ther., 29, 285, 10.1089/hum.2018.015

Le Guiner, 2017, Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy, Nat. Commun., 8, 16105, 10.1038/ncomms16105